ArticleCase studies in chemical and environmental engineering2020
Persistence, transmission, and infectivity of SARS-CoV-2 in inanimate environments.
Article in Case studies in chemical and environmental engineering, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 14 citations in OpenAlex.
- A review on detection of SARS-CoV-2 RNA in wastewater in light of the current knowledge of treatment process for removal of viral fragments.Journal of environmental management · 2021Review
- COVID-19 pandemic in Uttarakhand, India: Environmental recovery or degradation?Journal of environmental chemical engineering · 2021Article
- Non-Respiratory Droplet Transmission of COVID-19 in the Isolation Ward of a Secondary Hospital in Oman: A Return to Isolation Basics.Infectious diseases in clinical practice (Baltimore, Md.) · 2021Article
- The Safety of Slaughterhouse Workers during the Pandemic Crisis.International journal of environmental research and public health · 2021Article
- Study on the decay characteristics and transmission risk of respiratory viruses on the surface of objects.Environmental research · 2021Article
- SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis.PloS one · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, the emergence of a novel coronavirus, referred to as SARS-CoV-2, has become a global health concern which cause severe respiratory tract infections in humans. Person-to-person transmission of SARS-CoV-2 has occurred across the globe, within a short period of SARS-CoV-2 emergence. The goal of this analysis is to summarize in various inanimate surfaces and environments information about the frequency, persistence, potential dissemination, and infectivity of SARS-CoV-2. Most respiratory viruses, including coronaviruses, SARS-CoVs, or influenza may persist for a few days on the surfaces or objects. The length of tenacity on various inanimate surfaces depends on the environmental and growth conditions and overall survival rate could range from minutes to month time. The SARS-CoV-2 may survive and maintain infectivity in the air in unventilated buses for 30 min. As no specific vaccines or therapeutic drugs are available for this contagious virus, timely prevention measures would be crucial to control the future outbreak of this infectious disease. Precautionary strategies such as wearing masks and frequent washing hands are effective to mitigate COVID-19. Following careful consideration of the above-mentioned scenarios, the short review spotlights the pressing environmental issues regarding the persistence, transmission, and infectivity of SARS-CoV-2 in different environmental matrices. Aiming to address this issue with further and deeper insight into the SARS-CoV-2 emergence, a list of most concerned questions is given that should be carefully considered and answered in future studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.